

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.17587696 |
| 2 | chaperone-mediated protein transport (GO:0072321) | 4.91544126 |
| 3 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.81430569 |
| 4 | protein neddylation (GO:0045116) | 4.78547252 |
| 5 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.61930956 |
| 6 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.61746441 |
| 7 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.60836535 |
| 8 | regulation of mitochondrial translation (GO:0070129) | 4.36100294 |
| 9 | detection of calcium ion (GO:0005513) | 4.35346952 |
| 10 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.30565119 |
| 11 | termination of RNA polymerase III transcription (GO:0006386) | 4.17124221 |
| 12 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.17124221 |
| 13 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.16709121 |
| 14 | negative regulation of ligase activity (GO:0051352) | 4.16596000 |
| 15 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.16596000 |
| 16 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.16171018 |
| 17 | establishment of integrated proviral latency (GO:0075713) | 4.15429935 |
| 18 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.09546555 |
| 19 | NADH dehydrogenase complex assembly (GO:0010257) | 4.09546555 |
| 20 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.09546555 |
| 21 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.09096003 |
| 22 | cytochrome complex assembly (GO:0017004) | 4.08682596 |
| 23 | respiratory chain complex IV assembly (GO:0008535) | 4.07575584 |
| 24 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.04244451 |
| 25 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.04244451 |
| 26 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.04244451 |
| 27 | synaptic vesicle exocytosis (GO:0016079) | 4.04176406 |
| 28 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.02948646 |
| 29 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.02948646 |
| 30 | vocalization behavior (GO:0071625) | 3.96826592 |
| 31 | neuronal action potential propagation (GO:0019227) | 3.93580315 |
| 32 | protein maturation by protein folding (GO:0022417) | 3.88283208 |
| 33 | sequestering of actin monomers (GO:0042989) | 3.87637428 |
| 34 | establishment of viral latency (GO:0019043) | 3.87434967 |
| 35 | regulation of oxidative phosphorylation (GO:0002082) | 3.83240149 |
| 36 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.83028270 |
| 37 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.83028270 |
| 38 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.82465649 |
| 39 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.82019659 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.81687006 |
| 41 | DNA deamination (GO:0045006) | 3.79738958 |
| 42 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.78673478 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.78103919 |
| 44 | presynaptic membrane assembly (GO:0097105) | 3.76799098 |
| 45 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.76115576 |
| 46 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.74752900 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.73979399 |
| 48 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.71468947 |
| 49 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.71468947 |
| 50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.69058784 |
| 51 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.65241594 |
| 52 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.57009463 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 3.56021603 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.52208197 |
| 55 | postsynaptic membrane organization (GO:0001941) | 3.49546989 |
| 56 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48749825 |
| 57 | positive regulation of ligase activity (GO:0051351) | 3.47949144 |
| 58 | ribosomal large subunit biogenesis (GO:0042273) | 3.47457226 |
| 59 | pseudouridine synthesis (GO:0001522) | 3.46853516 |
| 60 | neuron cell-cell adhesion (GO:0007158) | 3.46516902 |
| 61 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.46295581 |
| 62 | glutamate secretion (GO:0014047) | 3.45903872 |
| 63 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.45044299 |
| 64 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.45044299 |
| 65 | cullin deneddylation (GO:0010388) | 3.45034029 |
| 66 | serotonin metabolic process (GO:0042428) | 3.42814923 |
| 67 | protein deneddylation (GO:0000338) | 3.42449833 |
| 68 | protein targeting to mitochondrion (GO:0006626) | 3.41707360 |
| 69 | glutamate receptor signaling pathway (GO:0007215) | 3.41242908 |
| 70 | protein localization to synapse (GO:0035418) | 3.41115527 |
| 71 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.40309715 |
| 72 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.40028659 |
| 73 | regulation of cellular amine metabolic process (GO:0033238) | 3.39347087 |
| 74 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.37245819 |
| 75 | presynaptic membrane organization (GO:0097090) | 3.37172110 |
| 76 | female mating behavior (GO:0060180) | 3.36776932 |
| 77 | platelet dense granule organization (GO:0060155) | 3.35366894 |
| 78 | neuron-neuron synaptic transmission (GO:0007270) | 3.35124656 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 3.34754232 |
| 80 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.31541203 |
| 81 | ATP synthesis coupled proton transport (GO:0015986) | 3.31541203 |
| 82 | protein-cofactor linkage (GO:0018065) | 3.29767418 |
| 83 | rRNA modification (GO:0000154) | 3.29138541 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.28369148 |
| 85 | respiratory electron transport chain (GO:0022904) | 3.27128377 |
| 86 | long-term synaptic potentiation (GO:0060291) | 3.25745410 |
| 87 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.23926852 |
| 88 | establishment of protein localization to mitochondrion (GO:0072655) | 3.23124858 |
| 89 | protein localization to mitochondrion (GO:0070585) | 3.21955755 |
| 90 | electron transport chain (GO:0022900) | 3.20862056 |
| 91 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.14998339 |
| 92 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.14085037 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.13412496 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.11059786 |
| 95 | transferrin transport (GO:0033572) | 3.08581845 |
| 96 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.07969716 |
| 97 | peptide hormone processing (GO:0016486) | 3.07697100 |
| 98 | cochlea development (GO:0090102) | 3.07072526 |
| 99 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.06745159 |
| 100 | primary amino compound metabolic process (GO:1901160) | 3.05842777 |
| 101 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.05422938 |
| 102 | mannosylation (GO:0097502) | 3.05237593 |
| 103 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04876108 |
| 104 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.02492799 |
| 105 | ribosomal small subunit assembly (GO:0000028) | 3.01860025 |
| 106 | regulation of ligase activity (GO:0051340) | 3.01768867 |
| 107 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.01179601 |
| 108 | endocrine pancreas development (GO:0031018) | 3.00586613 |
| 109 | base-excision repair, AP site formation (GO:0006285) | 3.00538961 |
| 110 | long term synaptic depression (GO:0060292) | 3.00062485 |
| 111 | intracellular protein transmembrane import (GO:0044743) | 3.00039795 |
| 112 | regulation of catecholamine metabolic process (GO:0042069) | 2.99606327 |
| 113 | regulation of dopamine metabolic process (GO:0042053) | 2.99606327 |
| 114 | response to histamine (GO:0034776) | 2.99518314 |
| 115 | chemosensory behavior (GO:0007635) | 2.99146526 |
| 116 | positive regulation of cell cycle arrest (GO:0071158) | 2.98460814 |
| 117 | negative regulation of protein ubiquitination (GO:0031397) | 2.96286262 |
| 118 | innervation (GO:0060384) | 2.95050341 |
| 119 | DNA damage response, detection of DNA damage (GO:0042769) | 2.94026814 |
| 120 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.93879196 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.93573916 |
| 122 | proton transport (GO:0015992) | 2.93559580 |
| 123 | translation (GO:0006412) | 2.93444882 |
| 124 | regulation of vesicle fusion (GO:0031338) | 2.91747435 |
| 125 | ferric iron transport (GO:0015682) | 2.91677365 |
| 126 | trivalent inorganic cation transport (GO:0072512) | 2.91677365 |
| 127 | ATP biosynthetic process (GO:0006754) | 2.87300741 |
| 128 | neurotransmitter secretion (GO:0007269) | 2.86540939 |
| 129 | behavioral response to cocaine (GO:0048148) | 2.86470921 |
| 130 | hydrogen transport (GO:0006818) | 2.85928584 |
| 131 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.85299397 |
| 132 | startle response (GO:0001964) | 2.84247874 |
| 133 | positive regulation of neurotransmitter transport (GO:0051590) | 2.81806147 |
| 134 | inner ear receptor cell development (GO:0060119) | 2.81685669 |
| 135 | positive regulation of membrane potential (GO:0045838) | 2.81575403 |
| 136 | regulation of female receptivity (GO:0045924) | 2.81410459 |
| 137 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.81410096 |
| 138 | protein localization to Golgi apparatus (GO:0034067) | 2.80747213 |
| 139 | insulin secretion (GO:0030073) | 2.80694869 |
| 140 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.80678115 |
| 141 | protein complex biogenesis (GO:0070271) | 2.80034849 |
| 142 | membrane repolarization during action potential (GO:0086011) | 2.79448136 |
| 143 | regulation of synaptic plasticity (GO:0048167) | 2.79274892 |
| 144 | regulation of postsynaptic membrane potential (GO:0060078) | 2.78850692 |
| 145 | inner mitochondrial membrane organization (GO:0007007) | 2.78642108 |
| 146 | 7-methylguanosine mRNA capping (GO:0006370) | 2.77871465 |
| 147 | synaptic vesicle endocytosis (GO:0048488) | 2.77102783 |
| 148 | negative regulation of amine transport (GO:0051953) | 2.75435257 |
| 149 | positive regulation of response to oxidative stress (GO:1902884) | 2.75408491 |
| 150 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.75408491 |
| 151 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.74530892 |
| 152 | cytidine deamination (GO:0009972) | 2.74142771 |
| 153 | cytidine metabolic process (GO:0046087) | 2.74142771 |
| 154 | cytidine catabolic process (GO:0006216) | 2.74142771 |
| 155 | metallo-sulfur cluster assembly (GO:0031163) | 2.74137496 |
| 156 | iron-sulfur cluster assembly (GO:0016226) | 2.74137496 |
| 157 | regulation of glutamate secretion (GO:0014048) | 2.72937701 |
| 158 | tRNA processing (GO:0008033) | 2.71016607 |
| 159 | cellular component biogenesis (GO:0044085) | 2.70862716 |
| 160 | 7-methylguanosine RNA capping (GO:0009452) | 2.70410580 |
| 161 | RNA capping (GO:0036260) | 2.70410580 |
| 162 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.69520124 |
| 163 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.69314078 |
| 164 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.69314078 |
| 165 | fear response (GO:0042596) | 2.68581072 |
| 166 | mitochondrial transport (GO:0006839) | 2.68167292 |
| 167 | righting reflex (GO:0060013) | 2.67877634 |
| 168 | Golgi transport vesicle coating (GO:0048200) | 2.67733931 |
| 169 | COPI coating of Golgi vesicle (GO:0048205) | 2.67733931 |
| 170 | neuron recognition (GO:0008038) | 2.66588253 |
| 171 | negative regulation of cation channel activity (GO:2001258) | 2.66574228 |
| 172 | signal transduction in response to DNA damage (GO:0042770) | 2.66472088 |
| 173 | negative regulation of catecholamine secretion (GO:0033604) | 2.66434640 |
| 174 | regulation of insulin secretion (GO:0050796) | 2.65664117 |
| 175 | ribosome assembly (GO:0042255) | 2.65327173 |
| 176 | exploration behavior (GO:0035640) | 2.65259368 |
| 177 | long-term memory (GO:0007616) | 2.63480424 |
| 178 | positive regulation of exocytosis (GO:0045921) | 2.63002958 |
| 179 | locomotory exploration behavior (GO:0035641) | 2.62762022 |
| 180 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.61634341 |
| 181 | cotranslational protein targeting to membrane (GO:0006613) | 2.61256866 |
| 182 | regulation of neuron projection regeneration (GO:0070570) | 2.61133234 |
| 183 | regulation of axon regeneration (GO:0048679) | 2.61133234 |
| 184 | cobalamin metabolic process (GO:0009235) | 2.60120131 |
| 185 | GTP biosynthetic process (GO:0006183) | 2.59706466 |
| 186 | negative regulation of telomere maintenance (GO:0032205) | 2.59245250 |
| 187 | hydrogen ion transmembrane transport (GO:1902600) | 2.58787758 |
| 188 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.58269345 |
| 189 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58269345 |
| 190 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.57378109 |
| 191 | positive regulation of vesicle fusion (GO:0031340) | 2.57107393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.61438795 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.30674330 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 5.07994456 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.39337658 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.31613212 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.82017348 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.73874590 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.49893666 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.45854475 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.37263718 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.18920504 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.94299842 |
| 13 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.85270788 |
| 14 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.77527013 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.75088192 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68099957 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65449215 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.55875779 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49390847 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.47751522 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46560901 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.40353209 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.38538654 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.34685534 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24755115 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19414665 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19273328 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18746133 |
| 29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17583008 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17294096 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.16735651 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.15013501 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.13287866 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09566825 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.05996304 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05601987 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02529039 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00069298 |
| 39 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99644798 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.99547346 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.98637395 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.97767996 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97575474 |
| 44 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97540901 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95942774 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95942774 |
| 47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95710831 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.95145901 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94742972 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90144320 |
| 51 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.86645515 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.84879947 |
| 53 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.83627065 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81877125 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80538270 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.80003168 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77654912 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77516724 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77211645 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.75764645 |
| 61 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.73063179 |
| 62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71663999 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.71363745 |
| 64 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71111823 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68606099 |
| 66 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.67006054 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64967907 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63990421 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63397118 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62903779 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61599020 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.60255225 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59146908 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58928284 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.56099655 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.55792056 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54710493 |
| 78 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52839711 |
| 79 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52423263 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52308153 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52000975 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51475150 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51376503 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50148724 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.49223756 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48263005 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45191094 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43669354 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41990866 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.40349725 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37490309 |
| 92 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37480475 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35738623 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35321300 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34861828 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33687616 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30177583 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.27549709 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.26575616 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26507632 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26168974 |
| 102 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24554290 |
| 103 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24400173 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24144065 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22776381 |
| 106 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21360516 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21311713 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18837233 |
| 109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18768930 |
| 110 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18028038 |
| 111 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.16966708 |
| 112 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16898050 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16773566 |
| 114 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16661580 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16159944 |
| 116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15658155 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15619098 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13548566 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12958476 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12781070 |
| 121 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.12386278 |
| 122 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11862812 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11308532 |
| 124 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10801526 |
| 125 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10801526 |
| 126 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09734251 |
| 127 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.09506632 |
| 128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08669478 |
| 129 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08355366 |
| 130 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07855903 |
| 131 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07808368 |
| 132 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06957949 |
| 133 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06346493 |
| 134 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.05827837 |
| 135 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05701818 |
| 136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05686432 |
| 137 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05276046 |
| 138 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05256794 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04583067 |
| 140 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04354388 |
| 141 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.03567914 |
| 142 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03418906 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03356524 |
| 144 | JUN_21703547_ChIP-Seq_K562_Human | 1.02722897 |
| 145 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.01122734 |
| 146 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00754945 |
| 147 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00564965 |
| 148 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00493697 |
| 149 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00426758 |
| 150 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00412204 |
| 151 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00369520 |
| 152 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99975501 |
| 153 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99769961 |
| 154 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99672886 |
| 155 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99279074 |
| 156 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99211672 |
| 157 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98498038 |
| 158 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98112367 |
| 159 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97495550 |
| 160 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97308949 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96356761 |
| 162 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96330080 |
| 163 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94459158 |
| 164 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.94354404 |
| 165 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94055091 |
| 166 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93950478 |
| 167 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93950478 |
| 168 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92695430 |
| 169 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92601794 |
| 170 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92123300 |
| 171 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.91961252 |
| 172 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88701821 |
| 173 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.88443454 |
| 174 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88338457 |
| 175 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.87482635 |
| 176 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.86556397 |
| 177 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.85776345 |
| 178 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84329126 |
| 179 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.80184929 |
| 180 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.78275781 |
| 181 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77709024 |
| 182 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77540593 |
| 183 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77540593 |
| 184 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76931218 |
| 185 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76594848 |
| 186 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.74773316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.65697937 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.06298151 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 3.07211943 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.04259228 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.95038554 |
| 6 | MP0004270_analgesia | 2.85760512 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.85140796 |
| 8 | MP0009745_abnormal_behavioral_response | 2.69361713 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.66135710 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.56310170 |
| 11 | MP0004043_abnormal_pH_regulation | 2.53748016 |
| 12 | MP0003786_premature_aging | 2.51706251 |
| 13 | MP0003123_paternal_imprinting | 2.47577866 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.44394803 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.43395596 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.40736927 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.39478474 |
| 18 | MP0002736_abnormal_nociception_after | 2.37355218 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.37200042 |
| 20 | MP0002822_catalepsy | 2.34227849 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.33348964 |
| 22 | MP0008058_abnormal_DNA_repair | 2.27965894 |
| 23 | MP0003718_maternal_effect | 2.26296503 |
| 24 | MP0002876_abnormal_thyroid_physiology | 2.24536800 |
| 25 | MP0002064_seizures | 2.24286682 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.19557660 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 2.18083491 |
| 28 | MP0002102_abnormal_ear_morphology | 2.17762239 |
| 29 | MP0003121_genomic_imprinting | 2.14357946 |
| 30 | MP0009697_abnormal_copulation | 2.11991945 |
| 31 | MP0003693_abnormal_embryo_hatching | 2.11574607 |
| 32 | MP0002272_abnormal_nervous_system | 2.06439035 |
| 33 | MP0008004_abnormal_stomach_pH | 2.04687339 |
| 34 | MP0003011_delayed_dark_adaptation | 1.99659920 |
| 35 | MP0003283_abnormal_digestive_organ | 1.91873423 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.88186383 |
| 37 | MP0003787_abnormal_imprinting | 1.86483806 |
| 38 | MP0001188_hyperpigmentation | 1.83444560 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.83370987 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.82865171 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.81055959 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.79626263 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.77555743 |
| 44 | MP0001529_abnormal_vocalization | 1.73768647 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.72244592 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.70785408 |
| 47 | MP0003879_abnormal_hair_cell | 1.69630134 |
| 48 | MP0001486_abnormal_startle_reflex | 1.68553688 |
| 49 | MP0009046_muscle_twitch | 1.68407133 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.66605250 |
| 51 | MP0003186_abnormal_redox_activity | 1.62844641 |
| 52 | MP0001664_abnormal_digestion | 1.60652107 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.57987378 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.57811808 |
| 55 | MP0001944_abnormal_pancreas_morphology | 1.56880958 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.55466859 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.55402025 |
| 58 | MP0003195_calcinosis | 1.53504464 |
| 59 | MP0003315_abnormal_perineum_morphology | 1.51321709 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.46776349 |
| 61 | MP0005085_abnormal_gallbladder_physiolo | 1.40346786 |
| 62 | MP0001970_abnormal_pain_threshold | 1.40016920 |
| 63 | MP0005332_abnormal_amino_acid | 1.39913289 |
| 64 | MP0003252_abnormal_bile_duct | 1.38612413 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.37784180 |
| 66 | MP0002163_abnormal_gland_morphology | 1.35309030 |
| 67 | MP0004147_increased_porphyrin_level | 1.35271344 |
| 68 | MP0001984_abnormal_olfaction | 1.34330289 |
| 69 | MP0001765_abnormal_ion_homeostasis | 1.33927549 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32150660 |
| 71 | MP0008007_abnormal_cellular_replicative | 1.30829551 |
| 72 | MP0003183_abnormal_peptide_metabolism | 1.30669810 |
| 73 | MP0005535_abnormal_body_temperature | 1.30267431 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.29800278 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.27752885 |
| 76 | MP0001905_abnormal_dopamine_level | 1.27186847 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.24983011 |
| 78 | MP0004924_abnormal_behavior | 1.24983011 |
| 79 | MP0001293_anophthalmia | 1.23150397 |
| 80 | MP0002938_white_spotting | 1.21471362 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.20140052 |
| 82 | MP0003122_maternal_imprinting | 1.19354584 |
| 83 | MP0000647_abnormal_sebaceous_gland | 1.18001457 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 1.12983238 |
| 85 | MP0005499_abnormal_olfactory_system | 1.12501822 |
| 86 | MP0005394_taste/olfaction_phenotype | 1.12501822 |
| 87 | MP0005365_abnormal_bile_salt | 1.11439968 |
| 88 | MP0002184_abnormal_innervation | 1.08343017 |
| 89 | MP0004133_heterotaxia | 1.07730795 |
| 90 | MP0003868_abnormal_feces_composition | 1.07543476 |
| 91 | MP0002653_abnormal_ependyma_morphology | 1.05312478 |
| 92 | MP0001764_abnormal_homeostasis | 1.04198953 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 1.02346530 |
| 94 | MP0005423_abnormal_somatic_nervous | 1.01448470 |
| 95 | MP0008995_early_reproductive_senescence | 1.01370908 |
| 96 | MP0005367_renal/urinary_system_phenotyp | 1.00804349 |
| 97 | MP0000516_abnormal_urinary_system | 1.00804349 |
| 98 | MP0008932_abnormal_embryonic_tissue | 1.00677720 |
| 99 | MP0000462_abnormal_digestive_system | 0.99455307 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.99156490 |
| 101 | MP0003329_amyloid_beta_deposits | 0.97976783 |
| 102 | MP0010094_abnormal_chromosome_stability | 0.97858867 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.97777231 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.95678118 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.95256586 |
| 106 | MP0004742_abnormal_vestibular_system | 0.94987074 |
| 107 | MP0008872_abnormal_physiological_respon | 0.94387205 |
| 108 | MP0002066_abnormal_motor_capabilities/c | 0.94213237 |
| 109 | MP0003953_abnormal_hormone_level | 0.92890204 |
| 110 | MP0003941_abnormal_skin_development | 0.91554191 |
| 111 | MP0002751_abnormal_autonomic_nervous | 0.90591827 |
| 112 | MP0005360_urolithiasis | 0.89623661 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.89396485 |
| 114 | MP0005551_abnormal_eye_electrophysiolog | 0.88676829 |
| 115 | MP0005636_abnormal_mineral_homeostasis | 0.88305698 |
| 116 | MP0000358_abnormal_cell_content/ | 0.87063350 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.86750628 |
| 118 | MP0006292_abnormal_olfactory_placode | 0.86655760 |
| 119 | MP0003633_abnormal_nervous_system | 0.86566342 |
| 120 | MP0008569_lethality_at_weaning | 0.85140383 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.85037673 |
| 122 | MP0004811_abnormal_neuron_physiology | 0.84909337 |
| 123 | MP0005253_abnormal_eye_physiology | 0.84021695 |
| 124 | MP0000427_abnormal_hair_cycle | 0.83443199 |
| 125 | MP0005395_other_phenotype | 0.81934437 |
| 126 | MP0000955_abnormal_spinal_cord | 0.81673682 |
| 127 | MP0000778_abnormal_nervous_system | 0.81518683 |
| 128 | MP0003119_abnormal_digestive_system | 0.81314725 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.80918049 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.80718200 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.80473007 |
| 132 | MP0002282_abnormal_trachea_morphology | 0.80066744 |
| 133 | MP0004142_abnormal_muscle_tone | 0.78888450 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.76940941 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.76903086 |
| 136 | MP0002234_abnormal_pharynx_morphology | 0.76549968 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.75986928 |
| 138 | MP0006036_abnormal_mitochondrial_physio | 0.75737815 |
| 139 | MP0002882_abnormal_neuron_morphology | 0.74980859 |
| 140 | MP0004145_abnormal_muscle_electrophysio | 0.74570660 |
| 141 | MP0005409_darkened_coat_color | 0.74056991 |
| 142 | MP0002229_neurodegeneration | 0.73984463 |
| 143 | MP0005266_abnormal_metabolism | 0.72990027 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.72600008 |
| 145 | MP0004484_altered_response_of | 0.72344867 |
| 146 | MP0001986_abnormal_taste_sensitivity | 0.72105222 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.71552655 |
| 148 | MP0003866_abnormal_defecation | 0.71195385 |
| 149 | MP0003950_abnormal_plasma_membrane | 0.71167980 |
| 150 | MP0004019_abnormal_vitamin_homeostasis | 0.70931842 |
| 151 | MP0005410_abnormal_fertilization | 0.68590054 |
| 152 | MP0001756_abnormal_urination | 0.67858441 |
| 153 | MP0001919_abnormal_reproductive_system | 0.67394191 |
| 154 | MP0000762_abnormal_tongue_morphology | 0.67114013 |
| 155 | MP0001853_heart_inflammation | 0.66327708 |
| 156 | MP0008775_abnormal_heart_ventricle | 0.65143359 |
| 157 | MP0002233_abnormal_nose_morphology | 0.64374933 |
| 158 | MP0000579_abnormal_nail_morphology | 0.64190251 |
| 159 | MP0002210_abnormal_sex_determination | 0.63956661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.18842138 |
| 2 | Visual hallucinations (HP:0002367) | 4.30859034 |
| 3 | Hyperventilation (HP:0002883) | 4.25559967 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.22355345 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.05085164 |
| 6 | Atonic seizures (HP:0010819) | 4.03585195 |
| 7 | Epileptic encephalopathy (HP:0200134) | 3.93690058 |
| 8 | Symptomatic seizures (HP:0011145) | 3.76586165 |
| 9 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.70664309 |
| 10 | Decreased circulating renin level (HP:0003351) | 3.68554169 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.65548360 |
| 12 | Acute encephalopathy (HP:0006846) | 3.65219705 |
| 13 | Hypoglycemic seizures (HP:0002173) | 3.62861793 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.62853199 |
| 15 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.56617273 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.56583559 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.56583559 |
| 18 | Absence seizures (HP:0002121) | 3.49383332 |
| 19 | Febrile seizures (HP:0002373) | 3.47373811 |
| 20 | Methylmalonic aciduria (HP:0012120) | 3.40126892 |
| 21 | Focal seizures (HP:0007359) | 3.35971020 |
| 22 | Methylmalonic acidemia (HP:0002912) | 3.34517941 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.09435080 |
| 24 | Dialeptic seizures (HP:0011146) | 3.09098245 |
| 25 | Increased CSF lactate (HP:0002490) | 3.05663901 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 3.05254143 |
| 27 | Increased serum lactate (HP:0002151) | 2.94960730 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 2.91318759 |
| 29 | Congenital, generalized hypertrichosis (HP:0004540) | 2.89157908 |
| 30 | Hepatocellular necrosis (HP:0001404) | 2.88055352 |
| 31 | Hyperactive renin-angiotensin system (HP:0000841) | 2.84836226 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 2.83562753 |
| 33 | Hepatic necrosis (HP:0002605) | 2.83161728 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.81301027 |
| 35 | Ketoacidosis (HP:0001993) | 2.81202627 |
| 36 | Myokymia (HP:0002411) | 2.80226939 |
| 37 | Hypoglycemic coma (HP:0001325) | 2.75456295 |
| 38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.73445727 |
| 39 | Oral leukoplakia (HP:0002745) | 2.68013703 |
| 40 | Anxiety (HP:0000739) | 2.66291340 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64959017 |
| 42 | Exertional dyspnea (HP:0002875) | 2.61346399 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.60910258 |
| 44 | Lethargy (HP:0001254) | 2.56185779 |
| 45 | Ventricular fibrillation (HP:0001663) | 2.54847356 |
| 46 | Pheochromocytoma (HP:0002666) | 2.54609924 |
| 47 | Pancreatic cysts (HP:0001737) | 2.52631121 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.51755794 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.51755794 |
| 50 | Hypsarrhythmia (HP:0002521) | 2.51158054 |
| 51 | Abnormal number of erythroid precursors (HP:0012131) | 2.46783451 |
| 52 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.45376765 |
| 53 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.41540574 |
| 54 | Progressive cerebellar ataxia (HP:0002073) | 2.41284708 |
| 55 | Sparse eyelashes (HP:0000653) | 2.40332495 |
| 56 | Cerebral edema (HP:0002181) | 2.39937851 |
| 57 | Optic disc pallor (HP:0000543) | 2.38499569 |
| 58 | Hypothermia (HP:0002045) | 2.37750556 |
| 59 | Pancreatic fibrosis (HP:0100732) | 2.37507545 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.37183552 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.34444161 |
| 62 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34165815 |
| 63 | Hyperglycemia (HP:0003074) | 2.32569322 |
| 64 | Amblyopia (HP:0000646) | 2.32064535 |
| 65 | True hermaphroditism (HP:0010459) | 2.30657062 |
| 66 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30344104 |
| 67 | Hyperglycinemia (HP:0002154) | 2.30282576 |
| 68 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.30260652 |
| 69 | Aplastic anemia (HP:0001915) | 2.29579736 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.27287239 |
| 71 | Abnormality of vitamin B metabolism (HP:0004340) | 2.26868461 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25846855 |
| 73 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.25448242 |
| 74 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.25448242 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.25448242 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.25448242 |
| 77 | Neuroendocrine neoplasm (HP:0100634) | 2.24981865 |
| 78 | Adrenal hypoplasia (HP:0000835) | 2.22796781 |
| 79 | Gait imbalance (HP:0002141) | 2.22433048 |
| 80 | Dysautonomia (HP:0002459) | 2.21439058 |
| 81 | Broad-based gait (HP:0002136) | 2.21145278 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.20794221 |
| 83 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.20051167 |
| 84 | Leukodystrophy (HP:0002415) | 2.19964221 |
| 85 | Agitation (HP:0000713) | 2.18205649 |
| 86 | Lactic acidosis (HP:0003128) | 2.16611393 |
| 87 | Abnormality of renin-angiotensin system (HP:0000847) | 2.16511976 |
| 88 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16297360 |
| 89 | Delusions (HP:0000746) | 2.16083197 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.15843269 |
| 91 | Pancytopenia (HP:0001876) | 2.15665106 |
| 92 | Sclerocornea (HP:0000647) | 2.12913998 |
| 93 | Syncope (HP:0001279) | 2.12580450 |
| 94 | Hyperphosphaturia (HP:0003109) | 2.12033407 |
| 95 | Dicarboxylic aciduria (HP:0003215) | 2.10939265 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10939265 |
| 97 | Macrocytic anemia (HP:0001972) | 2.08459748 |
| 98 | Renal Fanconi syndrome (HP:0001994) | 2.08207404 |
| 99 | Abnormality of methionine metabolism (HP:0010901) | 2.08066601 |
| 100 | Testicular atrophy (HP:0000029) | 2.07796471 |
| 101 | Respiratory difficulties (HP:0002880) | 2.07209683 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06765923 |
| 103 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05168244 |
| 104 | Hyperkalemia (HP:0002153) | 2.04883712 |
| 105 | Protruding tongue (HP:0010808) | 2.04028609 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 2.03594329 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 2.03398963 |
| 108 | Hyperalaninemia (HP:0003348) | 2.03398963 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03398963 |
| 110 | Abnormality of the labia minora (HP:0012880) | 2.03274796 |
| 111 | Hydroureter (HP:0000072) | 2.03142521 |
| 112 | Palpitations (HP:0001962) | 2.02204640 |
| 113 | Colon cancer (HP:0003003) | 2.01356058 |
| 114 | Glycosuria (HP:0003076) | 2.01087328 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 2.01087328 |
| 116 | CNS demyelination (HP:0007305) | 2.00580328 |
| 117 | Increased intramyocellular lipid droplets (HP:0012240) | 1.97485362 |
| 118 | Generalized aminoaciduria (HP:0002909) | 1.97064329 |
| 119 | Exercise intolerance (HP:0003546) | 1.96070200 |
| 120 | Nephronophthisis (HP:0000090) | 1.95257739 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 1.94700076 |
| 122 | Excessive salivation (HP:0003781) | 1.94415691 |
| 123 | Drooling (HP:0002307) | 1.94415691 |
| 124 | Truncal ataxia (HP:0002078) | 1.93098225 |
| 125 | Depression (HP:0000716) | 1.92319903 |
| 126 | Reticulocytopenia (HP:0001896) | 1.91543062 |
| 127 | Abnormality of renal resorption (HP:0011038) | 1.89243513 |
| 128 | Hypoplasia of the uterus (HP:0000013) | 1.89222652 |
| 129 | Respiratory failure (HP:0002878) | 1.89079179 |
| 130 | Blue irides (HP:0000635) | 1.87878395 |
| 131 | Oligomenorrhea (HP:0000876) | 1.85993849 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.83812336 |
| 133 | Ketosis (HP:0001946) | 1.83625763 |
| 134 | Onycholysis (HP:0001806) | 1.82949597 |
| 135 | Hypokalemia (HP:0002900) | 1.82745346 |
| 136 | Abnormal pancreas size (HP:0012094) | 1.81792949 |
| 137 | Poor eye contact (HP:0000817) | 1.80859168 |
| 138 | Prolonged partial thromboplastin time (HP:0003645) | 1.80489099 |
| 139 | Impaired smooth pursuit (HP:0007772) | 1.78990850 |
| 140 | X-linked dominant inheritance (HP:0001423) | 1.78441259 |
| 141 | Psychosis (HP:0000709) | 1.77883811 |
| 142 | Late onset (HP:0003584) | 1.77620505 |
| 143 | IgG deficiency (HP:0004315) | 1.77202252 |
| 144 | Abnormality of placental membranes (HP:0011409) | 1.76244475 |
| 145 | Amniotic constriction ring (HP:0009775) | 1.76244475 |
| 146 | Gout (HP:0001997) | 1.75954793 |
| 147 | Poor suck (HP:0002033) | 1.74436657 |
| 148 | Bradykinesia (HP:0002067) | 1.70893029 |
| 149 | Resting tremor (HP:0002322) | 1.70437004 |
| 150 | Abnormality of the fovea (HP:0000493) | 1.70433882 |
| 151 | Increased muscle lipid content (HP:0009058) | 1.70152002 |
| 152 | Cortical visual impairment (HP:0100704) | 1.69767053 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.69092256 |
| 154 | Emotional lability (HP:0000712) | 1.68932351 |
| 155 | Blindness (HP:0000618) | 1.68854835 |
| 156 | Absent eyebrow (HP:0002223) | 1.68360493 |
| 157 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.67929527 |
| 158 | Hyperaldosteronism (HP:0000859) | 1.67224052 |
| 159 | Unsteady gait (HP:0002317) | 1.66536997 |
| 160 | Rough bone trabeculation (HP:0100670) | 1.64475818 |
| 161 | Pendular nystagmus (HP:0012043) | 1.63736977 |
| 162 | Abnormality of glycine metabolism (HP:0010895) | 1.63453514 |
| 163 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.63453514 |
| 164 | Chronic bronchitis (HP:0004469) | 1.60708080 |
| 165 | Congenital stationary night blindness (HP:0007642) | 1.60525530 |
| 166 | Male pseudohermaphroditism (HP:0000037) | 1.60193551 |
| 167 | Abnormality of the renal medulla (HP:0100957) | 1.60033399 |
| 168 | Abnormality of vitamin metabolism (HP:0100508) | 1.59579831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.47269832 |
| 2 | EPHA4 | 4.34304725 |
| 3 | NTRK3 | 4.06621738 |
| 4 | MAP3K12 | 3.84463865 |
| 5 | CASK | 3.71429374 |
| 6 | RIPK4 | 3.25415900 |
| 7 | INSRR | 3.17817841 |
| 8 | MAP2K7 | 2.80169675 |
| 9 | TESK2 | 2.68670683 |
| 10 | NME1 | 2.67787587 |
| 11 | BUB1 | 2.52634708 |
| 12 | TRIM28 | 2.43513699 |
| 13 | TESK1 | 2.39049011 |
| 14 | MAP3K4 | 2.34624476 |
| 15 | BMPR2 | 2.34416328 |
| 16 | EPHA2 | 2.16312882 |
| 17 | LIMK1 | 2.15726591 |
| 18 | ZAK | 2.14232985 |
| 19 | NME2 | 2.13346248 |
| 20 | MAP4K2 | 2.07200686 |
| 21 | CDK19 | 2.05138650 |
| 22 | VRK1 | 2.04402388 |
| 23 | BCKDK | 2.02468530 |
| 24 | PLK2 | 2.00661572 |
| 25 | MAP2K4 | 1.98701849 |
| 26 | NUAK1 | 1.95916504 |
| 27 | DAPK1 | 1.84629661 |
| 28 | ARAF | 1.83503672 |
| 29 | FRK | 1.80994400 |
| 30 | DAPK2 | 1.79473399 |
| 31 | SRPK1 | 1.77593373 |
| 32 | AKT3 | 1.76005743 |
| 33 | MAPK15 | 1.72061901 |
| 34 | MINK1 | 1.66638627 |
| 35 | MAP3K2 | 1.61133052 |
| 36 | GRK5 | 1.59038412 |
| 37 | MAP3K9 | 1.53804707 |
| 38 | PASK | 1.52815153 |
| 39 | EIF2AK1 | 1.49641461 |
| 40 | EIF2AK3 | 1.47928630 |
| 41 | NEK1 | 1.43729226 |
| 42 | BRAF | 1.42808792 |
| 43 | DYRK2 | 1.38100759 |
| 44 | TNIK | 1.37925929 |
| 45 | CSNK1G3 | 1.37280261 |
| 46 | KDR | 1.31063954 |
| 47 | TLK1 | 1.24930400 |
| 48 | CAMK2B | 1.24829089 |
| 49 | GRK1 | 1.21514354 |
| 50 | CSNK1G2 | 1.21395799 |
| 51 | CSNK1G1 | 1.20103382 |
| 52 | CAMK2A | 1.18975719 |
| 53 | PRKCG | 1.16890331 |
| 54 | ERBB3 | 1.13736601 |
| 55 | NTRK1 | 1.13147649 |
| 56 | TAF1 | 1.12077495 |
| 57 | CAMKK2 | 1.11602454 |
| 58 | SIK3 | 1.09550124 |
| 59 | PIM2 | 1.08558548 |
| 60 | PLK3 | 1.08547096 |
| 61 | CSNK1A1L | 1.06984315 |
| 62 | CDK5 | 1.06538166 |
| 63 | STK16 | 1.03063753 |
| 64 | WNK4 | 1.02797997 |
| 65 | TXK | 0.99602564 |
| 66 | MET | 0.98950147 |
| 67 | EPHB2 | 0.98209886 |
| 68 | KSR1 | 0.97845892 |
| 69 | OXSR1 | 0.97777833 |
| 70 | PTK2B | 0.97442435 |
| 71 | MST1R | 0.96762794 |
| 72 | PRKCE | 0.95658755 |
| 73 | CDC7 | 0.93759357 |
| 74 | PRKD3 | 0.93631516 |
| 75 | PNCK | 0.91598391 |
| 76 | GRK7 | 0.89979321 |
| 77 | LMTK2 | 0.89938415 |
| 78 | MAP3K1 | 0.89686850 |
| 79 | CAMK2D | 0.86128329 |
| 80 | MAP3K13 | 0.83653565 |
| 81 | WNK3 | 0.83270448 |
| 82 | PBK | 0.81189274 |
| 83 | FER | 0.80863428 |
| 84 | PLK1 | 0.77928546 |
| 85 | CCNB1 | 0.76029819 |
| 86 | SCYL2 | 0.75442724 |
| 87 | CAMKK1 | 0.74765848 |
| 88 | TAOK3 | 0.74495412 |
| 89 | MYLK | 0.74155947 |
| 90 | DYRK1A | 0.73820334 |
| 91 | TSSK6 | 0.73263584 |
| 92 | BCR | 0.72581582 |
| 93 | EIF2AK2 | 0.72060539 |
| 94 | MARK1 | 0.71739544 |
| 95 | KSR2 | 0.67768188 |
| 96 | PHKG1 | 0.67540595 |
| 97 | PHKG2 | 0.67540595 |
| 98 | ERBB4 | 0.67049725 |
| 99 | ABL2 | 0.67045260 |
| 100 | ADRBK2 | 0.66094528 |
| 101 | HIPK2 | 0.65087569 |
| 102 | BRSK2 | 0.63064747 |
| 103 | SGK2 | 0.62902749 |
| 104 | MAPKAPK3 | 0.61033654 |
| 105 | FGR | 0.61004719 |
| 106 | CAMK2G | 0.60425599 |
| 107 | GRK6 | 0.60391972 |
| 108 | ADRBK1 | 0.59901991 |
| 109 | SGK1 | 0.57958566 |
| 110 | PINK1 | 0.57188471 |
| 111 | PAK4 | 0.56912634 |
| 112 | MAPK13 | 0.56431179 |
| 113 | FES | 0.55841750 |
| 114 | RPS6KA5 | 0.54945885 |
| 115 | MST4 | 0.54719034 |
| 116 | PRPF4B | 0.53585016 |
| 117 | NTRK2 | 0.53130856 |
| 118 | SGK223 | 0.52244051 |
| 119 | SGK494 | 0.52244051 |
| 120 | AURKA | 0.51723578 |
| 121 | CAMK1 | 0.51497483 |
| 122 | PRKACA | 0.51122482 |
| 123 | PIK3CA | 0.50442095 |
| 124 | MAP2K6 | 0.49517280 |
| 125 | ILK | 0.49403705 |
| 126 | BMPR1B | 0.48384380 |
| 127 | RAF1 | 0.47233814 |
| 128 | CSNK2A2 | 0.47202686 |
| 129 | PAK3 | 0.47032176 |
| 130 | AURKB | 0.47009737 |
| 131 | MAP2K1 | 0.46370761 |
| 132 | PRKCA | 0.46330947 |
| 133 | PRKCI | 0.45090390 |
| 134 | CDC42BPA | 0.44008328 |
| 135 | PAK6 | 0.42534628 |
| 136 | STK39 | 0.42296234 |
| 137 | CSNK2A1 | 0.41899163 |
| 138 | UHMK1 | 0.41803339 |
| 139 | PDPK1 | 0.41045908 |
| 140 | FLT3 | 0.40117750 |
| 141 | TIE1 | 0.39927323 |
| 142 | RPS6KA4 | 0.39892376 |
| 143 | STK38L | 0.38322103 |
| 144 | CDK3 | 0.37523995 |
| 145 | CSNK1A1 | 0.37081413 |
| 146 | TNK2 | 0.37046011 |
| 147 | MUSK | 0.36738776 |
| 148 | STK10 | 0.36062612 |
| 149 | TTK | 0.34343122 |
| 150 | MKNK2 | 0.34168279 |
| 151 | DAPK3 | 0.33860639 |
| 152 | SIK2 | 0.32889684 |
| 153 | PRKG2 | 0.32195136 |
| 154 | CDK8 | 0.31705225 |
| 155 | BRSK1 | 0.31101858 |
| 156 | STK38 | 0.30998490 |
| 157 | PRKCQ | 0.30400095 |
| 158 | PDK1 | 0.29681645 |
| 159 | PRKCZ | 0.29356972 |
| 160 | ATR | 0.29349547 |
| 161 | IRAK3 | 0.29315325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.08281371 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.86440652 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.39139846 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.03837422 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.00946465 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.87649257 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.68245158 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60992159 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.60572744 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.56123843 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55600063 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45173508 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.37694677 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36515133 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.31872407 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.25016343 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 2.23497347 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17649484 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 2.10781710 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.07448866 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.96672968 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.89409425 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.86222143 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80440104 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.79115574 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76606005 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.71590937 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.71534511 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.65018169 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.64530595 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.64076381 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62479631 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60797810 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.57157181 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56089106 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.55823755 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52640182 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48342051 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48316131 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44809149 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40033223 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.33211239 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32691689 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31068690 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30177535 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 1.25973973 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24013913 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23383518 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23355367 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.22371115 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22064003 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.21799794 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21636030 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21419829 |
| 55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21294920 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20861927 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19948668 |
| 58 | Spliceosome_Homo sapiens_hsa03040 | 1.19835765 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 1.19046576 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18757865 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17880206 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16716840 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16394338 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15360855 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14019730 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12453559 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 1.08964827 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08343362 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07925288 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04216785 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01848297 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98303594 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96908059 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93304756 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.92047897 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91060718 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91004869 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89613923 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87992514 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87234892 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86090208 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86008020 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84330772 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84019505 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83265625 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81359220 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.81261773 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80778466 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79139635 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79047544 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77564487 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75226294 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74595372 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72221788 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72055744 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70330752 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68857612 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67545587 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66405873 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.66198426 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66171275 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65766016 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65001741 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64887914 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63684191 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62937312 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.62886415 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61998842 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61942906 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61058647 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60679006 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.60349133 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59858769 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59395375 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58446639 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58210477 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56982574 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54359283 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53717695 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53510895 |
| 121 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52169967 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52113680 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52070153 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50355108 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50344240 |
| 126 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49875334 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49560728 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49079577 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48078174 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47620146 |
| 131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47475570 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47284271 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47257936 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47044707 |
| 135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45927176 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45482433 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.45106421 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42371273 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41310009 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40268510 |
| 141 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39460392 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37422325 |
| 143 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34507722 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34062650 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31832751 |
| 146 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31764040 |
| 147 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30792488 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.30785154 |
| 149 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29272526 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28402762 |
| 151 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28372002 |
| 152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28085036 |
| 153 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21563873 |
| 154 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21148008 |
| 155 | Alcoholism_Homo sapiens_hsa05034 | 0.19933680 |
| 156 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.19653915 |
| 157 | Glioma_Homo sapiens_hsa05214 | 0.19573096 |
| 158 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.19188016 |
| 159 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18840105 |
| 160 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17948657 |

